Interestingly, the analyses using neuropathological α-synuclein Braak staging in Parkinson’s disease cases suggest that hsa-miR-132-3p/-5p may play a role in the progressive accumulation of α-synuclein along the disease course, beyond the initial disease stages. This evidence concerns the gene SNCA and Parkinson disease.